Steve Schonfeld’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-676,621
| Closed | -$10.1M | – | 3004 |
|
|
2022
Q4 | $10.1M | Buy |
676,621
+580,848
| +606% | +$8.04M | 0.08% | 300 |
|
|
2022
Q3 | $788K | Sell |
95,773
-200,183
| -68% | -$1.54M | 0.01% | 1448 |
|
|
2022
Q2 | $1.94M | Buy |
295,956
+64,036
| +28% | +$310K | 0.02% | 755 |
|
|
2022
Q1 | $1.3M | Buy |
+231,920
| New | +$956K | 0.01% | 881 |
|
|
2021
Q1 | – | Sell |
-11,200
| Closed | -$65K | – | 2376 |
|
|
2020
Q4 | $65K | Buy |
+11,200
| New | +$64.1K | ﹤0.01% | 1485 |
|
|
2019
Q3 | – | Sell |
-2,271
| Closed | -$15K | – | 1348 |
|
|
2019
Q2 | $15K | Buy |
+2,271
| New | +$19.5K | ﹤0.01% | 953 |
|
|
2018
Q3 | – | Sell |
-5,000
| Closed | -$113K | – | 1118 |
|
|
2018
Q2 | $113K | Sell |
5,000
-2,533
| -34% | -$60.1K | 0.01% | 724 |
|
|
2018
Q1 | $219K | Sell |
7,533
-27,511
| -79% | -$805K | 0.02% | 672 |
|
|
2017
Q4 | $978K | Buy |
+35,044
| New | +$1.09M | 0.08% | 313 |
|
Steve Schonfeld's AVEO Position: Q1 2023 in Review
Steve Schonfeld sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 676,621 shares — an estimated $10.1M sold.
Steve Schonfeld first reported a position in AVEO in Q4 2017 and held it in 9 quarters. The position peaked at $10.1M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Steve Schonfeld reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Steve Schonfeld sold 676,621 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $10.1M.
- Steve Schonfeld first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 9 quarters.
- Steve Schonfeld's AVEO Pharmaceuticals, Inc. position peaked at $10.1M in Q4 2022.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.